Clinical Trial: NRG LU005

NRG LU005

Status: Closed

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab

LU005 is closed to accrual for US sites on June 23, 2022 at 5pm ET.